Comparative effectiveness of mineralocorticoid receptor antagonists in cardiorenal and metabolic disease
Mineralocorticoid receptor antagonists (MRAs) are foundational in cardiorenal therapy, yet head-to-head comparisons across specific clinical phenotypes are scarce. This real-world study evaluates the comparative effectiveness and safety of various MRAs in patients with heart failure (HF), chronic kidney disease (...